Skip to main content
. 2016 Jul 15;2(3):FSO135. doi: 10.4155/fsoa-2016-0030

Table 3. . Nanostructured lipid carriers fabricated using high pressure homogenization technique.

Active ingredient Solid lipid Liquid lipid Surfactants Size (nm) Research highlights Ref.
Bicalutamide
Precirol® ATO5
Triacetin
Phosal® 53 MCT, Pluronic® F-127, sodium taurocholate
130 ± 4.8 to 240 ± 4.1
Precirol® ATO 5 and Triacetin were found to be suitable lipids
High entrapment efficiency was achieved
[27]
Carvedilol
Glyceryl mono stearate
Oleic acid
Poloxamer 188, Tween 80
110
Desired particle size and percent entrapment efficiency were obtained for enhancement of oral bioavailability
[28]
Lovastatin
Precirol® ATO 5
Squalene
Myversol 18–04 K
278 ± 2.6
Pharmacokinetic parameters were improved after incorporation in NLCs
[19]
Luteolin
Precirol® ATO 5
Labrasol®
Cremophor ELP
43.89 ± 4.5
Luteolin's oral bioavailability improved after encapsulation in NLCs
[29]
Mitotane
Stearic acid
Triacyl glycerol
Tween 80, Span 85
250
NLCs can be successfully provided with positive charge for better mucosal adhesion
[30]
Oridonin
Glycerin monostearate
Medium chain triglyceride
Soyabean lecithin S100, poloxamer 188
144.9
Performance of Biotin-modified oridonin-loaded NLCs in bioavailability was significantly higher in comparison to nonmodified NLCs
[31]
Quercetin
Imwitor 900K
Medium chain triglyceride
Tween 80, lecthin, Span 20
˜34 to 47
Maximum bioaccessbility was observed with NLCs and lipid nanoemulsions compared with SLNs and drug solution
[32]
Spironolactone
Precirol® ATO 5
Miglyol 812
Tween 80, poloxamer 188
150 ± 5
Significant improvement in oral bioavailability of drug in comparison to drug syrup
High retention of radiolabeled NLCs in intestinal mucosa
[33]
Saquinavir
Precirol® ATO 5
Migylol 812
Tween 80, poloxamer 188
247
Hydrophilic P-gp substrate drugs can be effectively delivered through oral route after encapsulation in NLCs
[34]
Saquinavir mesylate
Precirol® ATO 5
Migylol 812
Tween 80, poloxamer 188
244 ± 1
Nine-fold increase in saquinavir permeability from Dextran-protamine NLCs in comparison to noncoated NLCs
[35]
Testosterone undecanoate
Dynasan188
Oleic acid
Tween 80
200
AUC values were found to be doubled in comparison to commercial formulations
[36]
Thistle oil, safflower oil, sea buckthorn oil, carrot extract
Glycerol monostearate
Cetyl alcohol, beeswax
Tween 20, phosphatidyl choline
70–140
NLCs demonstrated better antioxidant and anti-inflammatory properties due to synergistic effect of plant-derived oils and extract
[37]
Thymoquinone
Softisan® 154
Olive oil
Polysorbate 80
75 ± 2.4
Improved gastroprotective effects of drug
Pharmacokinetic properties of drug were improved after encapsulation in NLCs
[38]
Vinpocetine
Compritol 888 ATO
Migylol 812
Lecithin solutol HS-15
136 ± 4.2
Improved oral bioavailability of drug-loaded NLCs (322%) in comparison to drug suspension
[39]
Zerumbone Hydrogenated palm oil Olive oil, lipoid S100 Tween 80, thiomerasol 52.68 ± 0.1 NLCs showed no acute toxicity at oral doses of 100 and 200 mg/kg [40]

AUC: Area under curve; NLC: Nanostructured lipid carrier; SLN: Solid lipid nanoparticle.